$CHYM

Chime Financial, Inc.

CIK:0001795586|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 669,768	$ 528,149	$ 1,317,155	$ 1,046,893
Cost of revenue	74,895	67,120	141,969	127,538
Gross profit	594,873	461,029	1,175,186	919,355
Operating expenses:
Transaction and risk losses	103,287	98,247	192,192	207,392
Member support and operations	109,555	203,097	204,954	281,706
Sales and marketing	164,159	185,006	329,590	317,579
Technology and development	112,111	621,754	221,891	699,636
General and administrative	80,142	279,667	150,609	326,840
Depreciation and amortization	4,297	3,896	8,465	7,703
Total operating expenses	573,551	1,391,667	1,107,701	1,840,856
Income (loss) from operations	21,322	(930,638)	67,485	(921,501)
Other income, net	6,741	6,215	14,489	11,569
Net income (loss) before income taxes	28,063	(924,423)	81,974	(909,932)
Provision (benefit) for income taxes	213	(1,047)	668	505
Net income (loss)	$ 27,850	$ (923,376)	$ 81,306	$ (910,437)
Net income (loss) per share attributable to common stockholders:
Basic (in usd per share)	$ 0.07	$ (7.29)	$ 0.21	$ (9.44)
Diluted (in usd per share)	$ 0.07	$ (7.29)	$ 0.20	$ (9.44)
Weighted average number of common shares outstanding used to compute net income (loss) per share attributable to common stockholders:
Basic (in shares)	379,820,643	126,620,499	380,723,765	96,412,477
Diluted (in shares)	393,420,014	126,620,499	396,943,274	96,412,477

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities:
Net income (loss)	$ 81,306	$ (910,437)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	15,222	14,669
Non-cash lease expense	4,565	3,058
Stock-based compensation	130,052	918,843
Stock-based charitable contribution	1,495	11,168
Provision for transaction dispute losses	43,725	31,045
Change in fair value of product obligation	(52,282)	43,579
Provision for credit losses	29,362	44,096
Amortization of premium on marketable securities	(129)	(2,365)
Other	3,197	208
Changes in operating assets and liabilities:
Product collateral	46,381	(31,260)
Accounts receivable, net	(31,170)	(14,342)
Prepaid expenses and other assets	35,831	(1,432)
Accounts payable	(2,425)	15,954
Accrued and other liabilities	(45,614)	(93,291)
Operating lease liabilities	(3,784)	(7,773)
Settlements of the product obligation	39,224	(18,977)
Cash flows provided by operating activities	294,956	2,743
Investing activities:
Purchase of marketable securities	(235,641)	(234,050)
Proceeds from sales of marketable securities	0	256,514
Proceeds from maturities of marketable securities	292,300	123,200
Purchases of loans held for investment	(2,706,364)	(2,368,152)
Repayments of loans held for investment	2,652,466	2,311,634
Purchase of property, equipment and software	(16,560)	(3,631)
Capitalization of internal-use software	(832)	(6,389)
Cash flows provided by (used in) investing activities	(14,631)	79,126
Financing activities:
Payment of debt issuance costs	(905)	(1,134)
Proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts and offering costs paid	0	772,556
Taxes paid related to net share settlement of restricted stock units	(3,007)	(322,619)
Proceeds from borrowings under the warehouse facility	50,000	0
Proceeds from exercise of stock options	15,960	1,127
Repurchases of common stock	(222,074)	0
Cash flows provided by (used in) financing activities	(160,026)	449,930
Net increase in cash and cash equivalents and restricted cash	120,299	531,799
Cash, cash equivalents, and restricted cash, beginning of period	480,760	350,000
Cash, cash equivalents, and restricted cash, end of period	601,059	881,799
Cash and cash equivalents, end of the period	536,045	868,284
Restricted cash, end of the period	65,014	13,515
Cash, cash equivalents, and restricted cash, end of the period	601,059	881,799
Supplementary cash flow disclosure:
Cash paid for interest	246	140
Cash paid for income taxes, net of refunds received	1,020	1,043
Supplemental disclosures of noncash investing and financing activities:
Deferred offering costs not yet paid	0	1,968
Reclassification of deferred offering costs to additional paid-in capital upon initial public offering	0	14,815
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering	0	2,890,121
Purchases of property, equipment and software in accounts payable	$ 0	$ 294

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 536,045	$ 466,252
Restricted cash	65,014	14,508
Marketable securities	527,380	587,828
Product collateral	204,823	251,204
Accounts receivable, net	287,773	257,884
Loans held for investment, net	97,398	71,581
Prepaid expenses and other current assets	71,083	106,753
Total current assets	1,789,516	1,756,010
Property, equipment and software, net	97,429	94,320
Operating lease right of use assets, net	78,864	83,429
Other assets	30,840	30,846
Total assets	1,996,649	1,964,605
Current liabilities:
Accounts payable	36,255	38,680
Accrued and other current liabilities	216,638	201,862
Product obligation	134,324	147,382
Total current liabilities	387,217	387,924
Operating lease liabilities, net of current portion	117,847	123,284
Warehouse facility	50,000	0
Other non-current liabilities	36,763	51,691
Total liabilities	591,827	562,899
Commitments and contingencies (Note 18)
Stockholders’ equity:
Preferred stock, $0.0001 par value: 100,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025.	0	0
Additional paid-in capital	4,698,137	4,775,607
Accumulated other comprehensive income (loss)	(548)	172
Accumulated deficit	(3,292,798)	(3,374,104)
Total stockholders’ equity	1,404,822	1,401,706
Total liabilities and stockholders’ equity	1,996,649	1,964,605
Common Class A
Stockholders’ equity:
Common stock, issued	28	28
Common Class B
Stockholders’ equity:
Common stock, issued	3	3
Common Class C
Stockholders’ equity:
Common stock, issued	$ 0	$ 0